Muscular Dystrophies clinical trials at University of California Health

• ECoG BMI for Motor and Speech Control

  open to eligible people ages 21 years and up

  Test the feasibility of using electrocorticography (ECoG) signals to control complex devices for motor and speech control in adults severely affected by neurological disorders.

  at UCSF

• Biomarker Development in LGMD 2i

  Sorry, in progress, not accepting new patients

  The overall goal of this natural history study is to define the key LGMD2i phenotypes as measured by standard clinical outcome assessments (COAs), and to validate a muscle biomarker for LGMD 2i to support therapeutic development.

  at UC Irvine

• Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy (LGMD)

  Sorry, accepting new patients by invitation only

  Limb Girdle Muscular Dystrophy comprise a group of disorders made up of over 30 mutations which share a common phenotype of progressive weakness of the shoulder and hip girdle muscles. While the individual genetic mutations are rare, as a cohort, LGMDs are one of the four most common muscular dystrophies. The overall goal of project 1 is to define the key phenotypes as measured by standard clinical outcome assessments (COAs) for limb girdle muscular dystrophies (LGMD) to hasten therapeutic development.

  at UC Irvine

• Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy

  Sorry, in progress, not accepting new patients

  This study is a long-term study of ataluren in participants with nonsense mutation Duchenne muscular dystrophy.

  at UC Davis UCSF

Last updated: July 26, 2021